DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.7% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $396.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2026ACC: 0001310204-26-000016
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$396.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$132.27
Trade value
$396.81K
% of position
1.7%
5/15/2026
176.19K→173.19K
Total
Net shares
−3K
Net value
-$396.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | S · Sale | −3K | $132.27 | $396.81K | 1.7% | 176.19K | 173.19K |
| Total | −3K | -$396.81K | ||||||
Derivative Transactions0
No derivative transactions reported